Marie Lilly v. SSC Houston Southwest Operating Company LLC

CourtDistrict Court, S.D. Texas
DecidedJanuary 4, 2022
Docket4:20-cv-03478
StatusUnknown

This text of Marie Lilly v. SSC Houston Southwest Operating Company LLC (Marie Lilly v. SSC Houston Southwest Operating Company LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Marie Lilly v. SSC Houston Southwest Operating Company LLC, (S.D. Tex. 2022).

Opinion

UNITED STATES DISTRICT COURT January 04, 2022 SOUTHERN DISTRICT OF TEXAS Nathan Ochsner, Clerk HOUSTON DIVISION

MARIE LILLY, Individually and as a § Representative of the Estate of Edna § Spells, § § Plaintiff. § CIVIL ACTION NO. 4:20-cv-03478 § VS. § § SSC HOUSTON SOUTHWEST § OPERATING COMPANY LLC, § § Defendant. §

MEMORANDUM AND RECOMMENDATION Pending before me is Defendant SSC Houston Southwest Operating Company LLC’s Motion for Summary Judgment. See Dkt. 26. Having reviewed the briefing, the record, and the applicable law, I recommend that the motion be DENIED. BACKGROUND The Westchase Health and Rehabilitation Center (“Westchase”) is a skilled nursing and rehabilitation center operated by Defendant SSC Houston Southwest Operating Company LLC (“SSC”). Edna Spells (“Spells”) became a resident at Westchase in August 2011. In the early part of 2020, the COVID-19 pandemic quickly overwhelmed American society. We experienced a public health nightmare, faced unprecedented lockdowns, and witnessed widespread business failures. Thousands upon thousands of our fellow citizens died from this dreaded virus. One of those individuals was Spells. Spells took a COVID-19 test on April 20, 2020. Two days later, on April 22, the test results came back positive. Spells was taken by ambulance to Memorial Hermann Southwest Hospital on April 24, where she passed away the very next day. The death certificate lists her cause of death as COVID-19. Plaintiff Marie Lilly, individually and as a representative of Spells’s estate, filed this lawsuit in Texas state court, alleging state-law medical negligence claims against SSC. The case was timely removed to federal court on the basis of federal question and diversity jurisdiction. The thrust of the lawsuit is that SSC failed to properly monitor and care for Spells, which ultimately led to her exposure to, contraction of, and death from COVID-19. More specifically, the lawsuit alleges that SSC was negligent in its care, treatment, and provision of services to Spells. In particular, the lawsuit claims that SSC: a. Fail[ed] to institute an infection control program; b. Fail[ed] to implement an infection control program; c. Fail[ed] to observe, intervene, and care for EDNA SPELLS; d. Neglect[ed] EDNA SPELLS to such a degree that she was exposed to COVID-19; e. Fail[ed] to provide the medical and nursing care reasonably required for [Spells] known conditions[; and] f. Fail[ed] to provide the appropriate supervision and training to its staff and personnel that were providing care to [Spells] including appropriate care related to EDNA SPELLS’ treatment needs at all relevant times. Dkt. 1-2 at 5–6. SSC has filed a Motion for Summary Judgment, arguing that the Public Readiness and Emergency Preparedness Act (“PREP Act”), 42 U.S.C. §§ 247d-6d and 247d-6e, provides it with immunity from Plaintiff’s claims. SUMMARY JUDGMENT STANDARD Federal Rule of Civil Procedure 56 provides that summary judgment is proper when “there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” FED. R. CIV. P. 56(a). A dispute of material fact is “genuine” if the evidence would allow a reasonable jury to find in favor of 2 the nonmovant. See Rodriguez v. Webb Hosp. Corp., 234 F. Supp. 3d 834, 837 (S.D. Tex. 2017). To survive summary judgment, the nonmovant must “present competent summary judgment evidence to support the essential elements of its claim.” Cephus v. Tex. Health & Hum. Servs. Comm’n, 146 F. Supp. 3d 818, 826 (S.D. Tex. 2015). The nonmovant’s “burden will not be satisfied by some metaphysical doubt as to the material facts, by conclusory allegations, by unsubstantiated assertions, or by only a scintilla of evidence.” Boudreaux v. Swift Transp. Co., 402 F.3d 536, 540 (5th Cir. 2005) (quotation omitted). Rather, the “nonmovant must identify specific evidence in the record and articulate how that evidence supports that party’s claim.” Brooks v. Houston Indep. Sch. Dist., 86 F. Supp. 3d 577, 584 (S.D. Tex. 2015). In ruling on a motion for summary judgment, I must construe “the evidence in the light most favorable to the nonmoving party and draw all reasonable inferences in that party’s favor.” Cadena v. El Paso Cnty., 946 F.3d 717, 723 (5th Cir. 2020). ANALYSIS Enacted in 2005, the PREP Act provides broad immunity to entities and individuals responding to a national public health emergency.1 The key provision of the statue provides as follows: [A] covered person shall be immune from suit and liability under Federal and State law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a covered countermeasure if a declaration

1 The PREP Act further authorizes a compensation fund designed to provide “timely, uniform, and adequate compensation” through a no-fault claims process for injuries or deaths “directly caused by the administration or use of a covered countermeasure.” 42 U.S.C. § 247d-6e(a). The sole statutory exception to PREP Act immunity is for claims of willful misconduct causing death or serious injury. See id. § 247d-6d(d)(1). Such claims must be filed in the United States District Court for the District of Columbia. See id. § 247d-6d(e)(1).

3 [by the Secretary of Health and Human Services (“HHS”)] has been issued with respect to such countermeasure.

42 U.S.C. § 247d-6d(a)(1). A “covered person” includes manufacturers, distributors, and administrators of a covered countermeasure intended to combat a public health emergency. See id. § 247d-6d(i)(2). A “covered countermeasure” includes drugs, biological products, medical devices, respiratory protective devices, and any other “qualified pandemic or epidemic product.” See id. § 247d- 6d(i)(1). The PREP Act vests the HHS Secretary with authority to determine that a disease or other threat to health constitutes a public health emergency and to issue a declaration recommending administration of specified countermeasures. See id. § 247d-6d(b)(1). See also id. § 300hh (authorizing the HHS Secretary to carry out health-related activities to prepare for and respond effectively to public health emergencies). Immunity under the PREP Act is triggered when the HHS Secretary issues a declaration. See id. § 247d-6d(b)(1). In March 2020, the HHS Secretary issued a declaration regarding the COVID-19 pandemic. See Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15,198 (Mar. 17, 2020) (“Declaration”). The Declaration has been amended numerous times to expand its coverage; but, in essence, it recommends the use of various covered countermeasures to combat the COVID-19 pandemic and provides immunity from liability to covered persons administering or using covered countermeasures.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Boudreaux v. Swift Transportation Co.
402 F.3d 536 (Fifth Circuit, 2005)
April Cadena v. El Paso County
946 F.3d 717 (Fifth Circuit, 2020)
Brooks v. Houston Independent School District
86 F. Supp. 3d 577 (S.D. Texas, 2015)
Cephus v. Texas Health & Human Services Commission
146 F. Supp. 3d 818 (S.D. Texas, 2015)
Rodriguez v. Webb Hospital Corp.
234 F. Supp. 3d 834 (S.D. Texas, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Marie Lilly v. SSC Houston Southwest Operating Company LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/marie-lilly-v-ssc-houston-southwest-operating-company-llc-txsd-2022.